Lipodrene With 25mg Ephedra Extract 100CT
Recalling firm: Hi Tech Pharmaceuticals
Why it was recalled
The firm was notified by the FDA that the product contains the unapproved food additive 1,4-dimethylamylamine (DMAA).
Check your package
Compare the exact product and package details with the label you have.
ProductLipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9
UPC
857084000569FDA code information
Lot # 001211197, Exp. 12/25
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 857084000569 | Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9 |
| lot | 001211197 | Lot # 001211197, Exp. 12/25 |
Original FDA recall reason
The firm was notified by the FDA that the product contains the unapproved food additive 1,4-dimethylamylamine (DMAA).
Recall details
- Recall number
- F-0647-2021
- Event ID
- 87919
- FDA status
- Ongoing
- Initiated
- May 12, 2021
- Reported
- Jun 9, 2021
- Classified
- Jun 2, 2021
- Quantity
- 19,068/100 ct bottles
- Location
- Norcross, GA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
The product was shipped to the following states: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, MT, NC, NE, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, TN, TX, UT, VA, VT, WA & WI.
FDA source record · F-0647-2021
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.